Stay updated on Simufilam 100 mg in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.

Latest updates to the Simufilam 100 mg in Alzheimer's Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn NIH-wide banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” above the 403 error page. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe error page’s site revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now loads a 403 Forbidden error screen instead of the study record content, including a 403 text and a Home link. This change means the study details and related sections are not accessible on this page.SummaryDifference18%

- Check55 days agoChange DetectedThe page revision banner updated from v3.6.6 to v3.7.0, indicating a version update with no changes to study details.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This appears to be a minor administrative update to the page version with no changes to the study data or instructions.SummaryDifference0.0%

Stay in the know with updates to Simufilam 100 mg in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.